Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Protagonist Therapeutics Inc buy Truist Financial Co.

Start price
€21.80
09.09.24 / 50%
Target price
€54.34
09.09.25
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 09.09.25. The prediction end date can be changed by Truist_Financial_Co_ at any time.
Performance without dividends (%)
Name 1w
Protagonist Therapeutics Inc -
iShares Core DAX® -2.385%
iShares Nasdaq 100 -4.527%
iShares Nikkei 225® -4.129%
iShares S&P 500 -2.885%

Comments by Truist_Financial_Co_ for this prediction

In the thread Protagonist Therapeutics Inc diskutieren
Prediction Buy
Perf. (%) -
Target price 54.342
Change
Ends at 09.09.25

Protagonist Therapeutics, Inc. (NASDAQ: PTGX) is now covered by analysts at Truist Financial Co.. They set a "buy" rating and a $60.00 price target on the stock.
Ratings data for PTGX provided by MarketBeat